| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Mexico | 2 | |
| #2 | Peru | 2 | |
| #3 | United States | 2 | |
| #4 | Canada | 1 | |
| #5 | Chile | 1 | |
| #6 | China | 1 | |
| #7 | EPO (European Patent Office) | 1 | |
| #8 | Russian Federation | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Micro-structure and nano-technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Microorganisms | |
| #3 | Medical preparations | |
| #4 | Peptides | |
| #5 | Nanostructures |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lucio Decanini Eduardo | 9 |
| #2 | Toscano Contreras Arnulfo | 4 |
| #3 | Galiote Flores Alejandra | 4 |
| #4 | Morales Garzon Jose Andres | 3 |
| #5 | Eduardo Lucio Decanini | 2 |
| #6 | Absalón Constantino Angel Eduardo | 2 |
| #7 | Absalon Constantino Angel Eduardo | 2 |
| #8 | Cortes Espinosa Diana Veronica | 2 |
| #9 | José Andrés Morales Garzón | 2 |
| #10 | Morales Garzon José Andrés | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CN109195613A | The recombinant Newcastle disease virus of expression immune modulator as molecule adjuvant | |
| CA2956291A1 | Emulsified vaccine to obtain formulations of concentrated igy immunoglobulins; processes and uses for the same | |
| MX2010012602A | Newcastle disease virus and the use thereof as a vaccine. | |
| MX361884B | Aqueous inactivated vaccine for preventing avian influenza. |